Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Form 3 filing snapshot: On 21 Jul 2025 Patrick A. Mayes—newly appointed EVP & Chief Scientific Officer of Incyte Corp. (INCY)—submitted his initial statement of beneficial ownership.
- Direct equity: 67,388 common shares, the bulk of which are restricted stock units scheduled to vest between 2025-2028.
- Derivative exposure: 57,080 employee stock options across 15 grants; strike prices range from $61.18 to $106.47 with expirations from 2027-2035. Most awards are either fully vested or vest monthly/annually over four years.
The filing establishes Mayes as a Section 16 insider and documents equity-based incentives that align his compensation with shareholder value. No purchases or sales occurred, so immediate market impact is minimal.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.28%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.28%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many INCYTE (INCY) SEC filings are available on StockTitan?
StockTitan tracks 183 SEC filings for INCYTE (INCY), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for INCYTE (INCY)?
The most recent SEC filing for INCYTE (INCY) was filed on August 7, 2025.